MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
7.31
-0.05 (-0.68%)
Jun 18, 2026, 3:40 PM HKT
HKG:2235 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Depreciation & Amortization | 12.8 | 12.1 | 11.17 | 10.48 | 8.21 |
Other Amortization | 0.49 | - | - | 0.01 | 0.12 |
Loss (Gain) From Sale of Assets | -0.01 | - | - | - | -0.05 |
Asset Writedown & Restructuring Costs | 0 | 0.83 | 0.16 | 4.94 | - |
Loss (Gain) From Sale of Investments | -6.08 | -1.5 | 0.02 | - | - |
Stock-Based Compensation | - | - | - | - | 12.43 |
Provision & Write-off of Bad Debts | 1.53 | 1.44 | 0.99 | - | 1.23 |
Other Operating Activities | -14.99 | -45.98 | -46.39 | -64.58 | 15.87 |
Change in Accounts Receivable | -38.72 | -59.28 | -27.19 | -17.51 | -18.64 |
Change in Inventory | -37.38 | -12.46 | 21.7 | -35.41 | -16.29 |
Change in Accounts Payable | 68.33 | 42.12 | 11.56 | 18.09 | 6.52 |
Change in Unearned Revenue | - | - | - | - | -5.54 |
Change in Other Net Operating Assets | 6.48 | 5.2 | - | - | 0.07 |
Operating Cash Flow | 32.61 | -120.65 | -153 | -119.01 | -44.22 |
Capital Expenditures | -38.92 | -83.24 | - | -29.78 | -17.6 |
Sale of Property, Plant & Equipment | 0.03 | - | - | - | 0.05 |
Sale (Purchase) of Intangibles | - | - | -28.7 | - | -1.12 |
Investment in Securities | -298.92 | 207.4 | -505.93 | -359.66 | 116.36 |
Other Investing Activities | -23.13 | -3.01 | -6.07 | - | - |
Investing Cash Flow | -360.93 | 121.16 | -540.7 | -389.44 | 97.69 |
Short-Term Debt Issued | 63.87 | 49 | - | - | - |
Total Debt Issued | 63.87 | 49 | - | - | - |
Short-Term Debt Repaid | - | -49 | - | - | - |
Long-Term Debt Repaid | -0.51 | -0.49 | -0.56 | -0.5 | -0.17 |
Total Debt Repaid | -0.51 | -49.49 | -0.56 | -0.5 | -0.17 |
Net Debt Issued (Repaid) | 63.36 | -0.49 | -0.56 | -0.5 | -0.17 |
Issuance of Common Stock | - | - | - | - | 1,657 |
Repurchase of Common Stock | -6.65 | -31.79 | -22.9 | - | - |
Common Dividends Paid | -0.02 | -0.66 | - | - | - |
Other Financing Activities | -0 | -0.21 | - | -20.07 | -83.03 |
Financing Cash Flow | 56.68 | -33.15 | -23.46 | -20.57 | 1,574 |
Foreign Exchange Rate Adjustments | -16.41 | 5.88 | -1.65 | 27.1 | -16.48 |
Net Cash Flow | -288.04 | -26.76 | -718.81 | -501.93 | 1,611 |
Free Cash Flow | -6.31 | -203.88 | -153 | -148.79 | -61.82 |
Free Cash Flow Margin | -0.95% | -58.99% | -60.42% | -85.71% | -40.83% |
Free Cash Flow Per Share | -0.01 | -0.48 | -0.35 | -0.34 | -0.17 |
Cash Interest Paid | - | - | - | - | 0.02 |
Cash Income Tax Paid | 5.57 | 5.95 | -0.64 | -2.87 | - |
Levered Free Cash Flow | -32.8 | -143.41 | -126.24 | -146.24 | -50.98 |
Unlevered Free Cash Flow | -32.72 | -142.98 | -126.21 | -146.14 | -50.97 |
Change in Working Capital | -1.29 | -24.42 | 6.07 | -34.83 | -33.88 |